Literature DB >> 17915130

[Incidence and mortality of massive transfusion in a university hospital: study of the period 2001-2005].

Arturo Campos1, Manuel Muñoz, José Antonio García-Erce, Gemma Ramírez.   

Abstract

BACKGROUND AND
OBJECTIVE: There are few epidemiological studies on massive transfusion (MT), although they may be important to evaluate possible strategies to reduce the number of transfused units, as well as transfusion side-effects. We, therefore, retrospectively assessed the incidence of MT at our institution (a 700-bed university hospital) during a 5-year period. PATIENTS AND
METHOD: Local blood bank records were searched for MT episodes occurred from January 2001 to December 2005. MT was defined as the transfusion of 8 or more packed red cell (PRC) units within 24 h. Patient's clinical data were exclusively gathered from the blood requesting form.
RESULTS: Overall, 304 episodes of MT were identified in 288 patients (one episode per week), who received 4,845 PCR units (3,515 units within the first 24 h), because of ruptured aortic aneurism (n = 62), poly-trauma (n = 57), upper digestive bleeding (n = 51), cardiac surgery (n = 41), elective surgery (n = 36), emergency surgery (n = 30), and oncology surgery (n = 27). Mortality rate was 48%, and multivariate analysis identified age (odds ratio [OR] =1.023; 95% confidence interval [CI]. 1.006-1.040) and number of PRC transfused within the first 24 h (OR = 1.094; 95% CI, 1.0032-1.160) as weak but significant independent predictors of mortality, whereas poly-trauma diagnosis was a protective factor (OR = 0.325; 95% CI, 0.112 - 0,940).
CONCLUSIONS: Overall, the mortality rate among patients receiving MT was very high, and was influenced by the number of transfused units, patient's age, and admitting diagnose. As the majority of the MT episodes occurred within the surgical or polytrauma context, possible strategies to reduce the volume of MT are discussed.

Entities:  

Mesh:

Year:  2007        PMID: 17915130     DOI: 10.1157/13110210

Source DB:  PubMed          Journal:  Med Clin (Barc)        ISSN: 0025-7753            Impact factor:   1.725


  3 in total

Review 1.  Blood transfusion for the treatment of acute anaemia in inflammatory bowel disease and other digestive diseases.

Authors:  José Antonio García-Erce; Fernando Gomollón; Manuel Muñoz
Journal:  World J Gastroenterol       Date:  2009-10-07       Impact factor: 5.742

2.  Improving decision making for massive transfusions in a resource poor setting: a preliminary study in Kenya.

Authors:  Elisabeth D Riviello; Stephen Letchford; Earl Francis Cook; Aaron B Waxman; Thomas Gaziano
Journal:  PLoS One       Date:  2015-05-28       Impact factor: 3.240

3.  Improving outcomes for hospital patients with critical bleeding requiring massive transfusion: the Australian and New Zealand Massive Transfusion Registry study methodology.

Authors:  J C Oldroyd; K M Venardos; N J Aoki; A J Zatta; Z K McQuilten; L E Phillips; N Andrianopoulos; D J Cooper; P A Cameron; J P Isbister; E M Wood
Journal:  BMC Res Notes       Date:  2016-10-06
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.